Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus

The Risk of Transfusion-Transmitted Viral Infections

1996 • 1,893 citations

Dynamics of HIV viremia and antibody seroconversion in plasma donors

2003 • 1,219 citations

Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing

2004 • 532 citations

A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors

2005 • 421 citations

The cost‐effectiveness of NAT for HIV, HCV, and HBV in whole‐blood donations

2003 • 267 citations

Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection

2003 • 263 citations

Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting

1999 • 257 citations

Dynamics of viremia in early hepatitis C virus infection

2005 • 202 citations

The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection

1997 • 171 citations

International Forum: 1

2005 • 154 citations

Current incidence and estimated residual risk of transfusion‐transmitted infections in donations made to Canadian Blood Services

2007 • 152 citations

Assessing the impact of HBV NAT on window period reduction and residual risk

2006 • 115 citations

Failure of Routine HIV-1 Tests in a Case Involving Transmission With Preseroconversion Blood Components During the Infectious Window Period

2000 • 108 citations

Testing Strategy To Identify Cases of Acute Hepatitis C Virus (HCV) Infection and To Project HCV Incidence Rates

2007 • 101 citations

First report of human immunodeficiency virus transmission via an RNA‐screened blood donation

2004 • 98 citations

Human immunodeficiency virus, hepatitis C and hepatitis B infections among blood donors in Germany 2000-2002: risk of virus transmission and the impact of nucleic acid amplification testing

2005 • 96 citations

Trends in residual risk of transfusion‐transmitted viral infections in France between 1992 and 2000

2002 • 96 citations

Sensitivity of HCV core antigen and HCV RNA detection in the early infection phase

2002 • 90 citations

Real time TaqMan PCR detection and quantitation of HBV genotypes A–G with the use of an internal quantitation standard

2003 • 82 citations

Mini‐pool screening by nucleic acid testing for hepatitis B virus, hepatitis C virus, and HIV: preliminary results

1998 • 78 citations

Results of Viral Marker Screening of Unpaid Blood Donations and Probability of Window Period Donations in 1997

2000 • 77 citations

Prevalence of antibodies against hepatitis C virus in the adult German population

1999 • 75 citations

HBV: amplified and back in the blood safety spotlight

2001 • 73 citations

Estimated risk of transfusion‐transmitted viral infections in Spain

2002 • 72 citations

Hepatitis B virus genotype G monoinfection and its transmission by blood components

2006 • 61 citations

NAT screening of blood and plasma donations: evolution of technology and regulatory policy*

2002 • 60 citations

Residual risk of transfusion‐transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy

2005 • 59 citations

Transfusion‐transmitted viral infections: building bridges to transfusion medicine to reduce risks and understand epidemiology and pathogenesis

2006 • 58 citations

Demographic characteristics and prevalence of serologic markers among donors who use the confidential unit exclusion process: the Retrovirus Epidemiology Donor Study

1994 • 58 citations

Superiority of minipool nucleic acid amplification technology for hepatitis B virus over chemiluminescence immunoassay for hepatitis B surface antigen screening

2003 • 48 citations

Results of Viral Marker Screening of Unpaid Blood Donations and Probability of Window Period Donations in 1997

2000 • 45 citations

Antigen testing for human immunodeficiency virus (HIV) and the magnet effect: will the benefit of a new HIV test be offset by the numbers of higher risk, test‐seeking donors attracted to blood centers? Retrovirus Epidemiology Donor Study

1996 • 42 citations

First case of hepatitis C virus transmission by a red blood cell concentrate after introduction of nucleic acid amplification technique screening in Germany: a comparative study with various assays

2007 • 39 citations

Current impact of the confidential unit exclusion option

2004 • 39 citations

The German experience with NAT

2002 • 39 citations

HIV seroconverting donors delay their return: screening test implications

2002 • 25 citations

PCR for HVC, HCV and HIV-1 Experiences and First Results from a Rountine Screening Programme in a Large Blood Transfusion Service

1998 • 25 citations

Recent experience with human immunodeficiency virus transmission by cellular blood products in Germany: antibody screening is not sufficient to prevent transmission

2002 • 10 citations

Verzicht auf die Bestimmung der Alanin-Aminotransferase (ALT) als Freigabekriterium f�r Blutkomponenten zur Transfusion und Plasma zur Fraktionierung

2004 • 3 citations

Verzicht auf die Bestimmung der Alanin-Aminotransferase (ALT) als Freigabekriterium für Blutkomponenten zur Transfusion und Plasma zur Fraktionierung, Votum 30

2004 • 3 citations

Polymerase Chain Reaction and Viral Safety of Plasma Products: A Manufacturer’s View

1998 • 3 citations